<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Frederiksen | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/camerawall49/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/camerawall49/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Frederiksen.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">baade94ca4fb354f2345e853530076aa</guid>
				<title>Frederiksen posted an update: Microglia, which are tissue-resident macrophages in the [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42845/</link>
				<pubDate>Sun, 09 Feb 2025 11:41:08 -0800</pubDate>

									<content:encoded><![CDATA[<p>Microglia, which are tissue-resident macrophages in the brain, play a central role in the brain innate immunity and contribute to the maintenance of brain homeostasis. Lipopolysaccharide is a component of the outer membrane of gram-negative bacteria, and activates immune cells including microglia via Toll-like receptor 4 signaling.&hellip;<span class="activity-read-more" id="activity-read-more-42845"><a href="http://www.nationalboardinstitute.com/activity/p/42845/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9c66be61338f3d80c72db5a74d2e0c82</guid>
				<title>Frederiksen posted an update: 81.3 %, P = 0.04), but no difference was found compa [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41915/</link>
				<pubDate>Sat, 08 Feb 2025 11:32:29 -0800</pubDate>

									<content:encoded><![CDATA[<p>81.3 %, P = 0.04), but no difference was found compared with the FCSEMSs (50 % vs. 43.8 %, P = 0.698). Technical success was 100 %, with no differences in 30-day mortality P = 0.105). The adverse events rate was 4.2 % for both groups (index n = 1, referents n = 2). Of 11 removed 12-Fr plastic stents suspected to be dysfunctional, 7 (64 %) were&hellip;<span class="activity-read-more" id="activity-read-more-41915"><a href="http://www.nationalboardinstitute.com/activity/p/41915/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a63d6c7716759a89d058b575e09484e9</guid>
				<title>Frederiksen posted an update: The benefit of PARP inhibitor olaparib in relapsed and [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40441/</link>
				<pubDate>Thu, 06 Feb 2025 16:24:19 -0800</pubDate>

									<content:encoded><![CDATA[<p>The benefit of PARP inhibitor olaparib in relapsed and advanced high-grade serous ovarian carcinoma (HGSOC) is well established especially in BRCA1/2 mutation carriers. Identification of additional biomarkers can help expand the population of patients most likely to benefit from olaparib treatment. To identify candidate markers of olaparib&hellip;<span class="activity-read-more" id="activity-read-more-40441"><a href="http://www.nationalboardinstitute.com/activity/p/40441/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b88f30904c4f4ea8445c4340ccd44886</guid>
				<title>Frederiksen posted an update: In China, there has been a precipitous increase in the [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36683/</link>
				<pubDate>Sun, 02 Feb 2025 11:38:23 -0800</pubDate>

									<content:encoded><![CDATA[<p>In China, there has been a precipitous increase in the number of percutaneous coronary interventions (PCI) conducted. We sought to characterize the clinical and psychosocial trajectory of PCI patients from the time of procedure through 6months post, and correlates of adverse cardiovascular events (ACEs).</p>
<p> In this prospective, observational&hellip;<span class="activity-read-more" id="activity-read-more-36683"><a href="http://www.nationalboardinstitute.com/activity/p/36683/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">76e4d626613ceceb5cf085f075b2909c</guid>
				<title>Frederiksen posted an update: Both of the sites occur in regions of barstar with [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34935/</link>
				<pubDate>Fri, 31 Jan 2025 12:11:35 -0800</pubDate>

									<content:encoded><![CDATA[<p>Both of the sites occur in regions of barstar with relatively high conformational flexibility. Nevertheless, destabilization appears to occur through different thermodynamic mechanisms, involving a reduction in entropy in one case and a loss in enthalpy in another. By contrast, ubiquitination at a nondestabilizing site protects the substrate C&hellip;<span class="activity-read-more" id="activity-read-more-34935"><a href="http://www.nationalboardinstitute.com/activity/p/34935/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">937eacd16ca915a4a4e58d69fd641e84</guid>
				<title>Frederiksen posted an update: There was an interaction with genotype for attention, [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33936/</link>
				<pubDate>Thu, 30 Jan 2025 11:21:27 -0800</pubDate>

									<content:encoded><![CDATA[<p>There was an interaction with genotype for attention, processing speed, and executive functioning domain scores (Beta = 0.32, 95% confidence interval = 0.00 to 0.65); the chemotherapy group with an ε2 allele had higher scores at baseline and maintained higher scores over time compared with those without an ε2 allele, and this protective effec&hellip;<span class="activity-read-more" id="activity-read-more-33936"><a href="http://www.nationalboardinstitute.com/activity/p/33936/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5b8e85fa679634fb78d20c65c24e0d96</guid>
				<title>Frederiksen posted an update: Importantly, Ido1-/-Gr-1+CD11b+ cells exhibited elevated [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30549/</link>
				<pubDate>Tue, 28 Jan 2025 15:21:46 -0800</pubDate>

									<content:encoded><![CDATA[<p>Importantly, Ido1-/-Gr-1+CD11b+ cells exhibited elevated levels of reactive oxygen species (ROS) and neutrophil numbers. These characteristics were rescued by human IDO1 with intact heme-binding and catalytic activities and were recapitulated by the treatment of WT cells with the IDO1 inhibitor L1-methyl tryptophan. ROS scavenging by&hellip;<span class="activity-read-more" id="activity-read-more-30549"><a href="http://www.nationalboardinstitute.com/activity/p/30549/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6a0bc56dc8cbc399676f2cd0c30e912f</guid>
				<title>Frederiksen became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30520/</link>
				<pubDate>Tue, 28 Jan 2025 15:18:13 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>